Zevra Therapeutics, Inc.

ZVRA·NasdaqGS·Healthcare
Compare
11.17+0.91 (+8.87%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.26
Open10.53
Day range10.5311.19
52-week range8.0115.04
Off day high−0.18%
Off 52-week high−25.71%
Volume2.06M
Avg. volume (3M)895.89K
Market cap663.32M
EPS (TTM)1.22
Forward P/E10.37
P/E ratio (TTM)9.16
Dividend yield—
Beta (5Y)0.99
Shares outstanding59.38M
Short interest10.61% of float
Earnings dateNov 3, 2026
Analyst target25.25
Profit margin42.82%

Against its peers

Compare in full ›
ZVRA SLDB KROS DSGN OVID LXRX
Market cap 663.32M 699.11M 214.73M 665.24M 535.12M 658.53M
P/E (TTM) 9.2 — — — — —
Forward P/E 10.4 -3.8 -1.6 -6.6 -7.5 -7.8
Price/book 2.8 2.9 0.8 3.0 2.4 3.8
Dividend yield — — — — — —
1-year change +22.88% +54.69% −33.02% +54.73% +80.45% +3.50%
Today +8.87% +3.82% 0.00% +2.80% +14.17% +1.37%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Zevra Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Solid Biosciences Inc.SLDB · Biotechnology 699.11M 6.52 +3.82%
Keros Therapeutics, Inc.KROS · Biotechnology 214.73M 10.83 0.00%
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%
Ovid Therapeutics Inc.OVID · Biotechnology 535.12M 2.7400 +14.17%
Lexicon Pharmaceuticals, Inc.LXRX · Biotechnology 658.53M 1.4800 +1.37%
Geron CorporationGERN · Biotechnology 693.87M 1.0800 +16.13%
BioArctic AB (publ)B9A.F · Biotechnology 2.45B 27.58 −0.29%
Maze Therapeutics, Inc.MAZE · Biotechnology 1.85B 33.38 +3.50%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Bicara Therapeutics Inc.BCAX · Boston, MA 588.28M 8.89 −0.78%
Arbutus Biopharma CorporationABUS · Warminster, PA 622.30M 4.0600 +4.64%
Geron CorporationGERN · Foster City, CA 693.87M 1.0800 +16.13%
Aclaris Therapeutics, Inc.ACRS · Wayne, PA 570.34M 3.6800 −1.60%
Iambic Therapeutics, Inc.IAM · San Diego, CA 635.17M 13.40 −0.67%
Adlai Nortye Group Ltd.ANL · Singapore, Singapore 618.86M 9.61 +0.31%
Apnimed, Inc.APMD · Cambridge, MA 636.95M 15.30 +1.59%
Climb Bio, Inc.CLYM · Wellesley Hills, MA 535.88M 9.33 −4.31%

Also based in Boston, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%
Wayfair Inc.W · Boston, MA 16.92B 123.56 +11.00%
State Street CorporationSTT · Boston, MA 47.18B 173.41 +2.18%
PTC Inc.PTC · Boston, MA 21.20B 195.18 +0.58%
Toast, Inc.TOST · Boston, MAOdds 20.44B 35.37 +5.49%
Dynatrace, Inc.DT · Boston, MA 13.42B 46.78 −0.53%
BXP, Inc.BXP · Boston, MA 11.93B 65.96 +5.32%

The stocks whose daily moves over the past year went most closely with Zevra Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Mineralys Therapeutics, Inc.MLYS · Correlation 0.35 1.50B 17.00 +6.32%
Solid Biosciences Inc.SLDB · Correlation 0.33 699.11M 6.52 +3.82%
Maze Therapeutics, Inc.MAZE · Correlation 0.32 1.85B 33.38 +3.50%
Rhythm Pharmaceuticals, Inc.RYTM · Correlation 0.31 7.67B 110.68 +28.04%
Arbutus Biopharma CorporationABUS · Correlation 0.31 622.30M 4.0600 +4.64%

What visitors to Zevra Therapeutics's page also look at.

Company Mkt cap Price Today
Aduro Clean Technologies Inc.ADUR 353.12M 9.87 +5.67%
Mineralys Therapeutics, Inc.MLYS 1.50B 17.00 +6.32%
Monte Rosa Therapeutics, Inc.GLUE 923.09M 10.82 +3.94%
Phathom Pharmaceuticals, Inc.PHAT 461.74M 5.68 −1.05%
Travere Therapeutics, Inc.TVTX 5.03B 52.42 +6.09%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ZVRA news ›
Stock Titan·

Zevra Therapeutics insider reports $228K share sale

A 20,000-share sale was reported by Zevra Therapeutics (ZVRA) director Neil F. McFarlane. Stock Titan Zevra Therapeutics insider reports $228K share sale The notice lists 59,383,781 common shares outstanding. Sentiment and the balance of…

BLND

From the 4Search news index, newest first.

In the news

13mentions in 30 days
11with it in the headline
Positivesentiment

Mentioned with

Zevra Therapeutics, Inc.9Zevia Pbc5Zvra Zevra Therapeutics, Inc5Astrazeneca4Brokerages4U.S. Food and Drug Administration4Zevra Therapeutics, Inc4Arcturus Therapeutics Holdings Inc3

People in the coverage

Mitch Edgeman8Neil F. Mcfarlane7Tristan Rich7Danessa Lincoln5Kim Johansen4Michael Walen4

Themes

Healthcare12SEC Filings8Biotechnology6Therapeutics6Quarter4Results4Second4Earnings3

Most coverage from

  1. seekingalpha.com5
  2. defenseworld.net2
  3. themarketsdaily.com2
  4. globenewswire.com1
  5. stocktitan.net1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance